참고문헌
- Andersson E, Karrberg C, Radberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P. Type-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia. J Clin Microbiol. 2011. 49: 3794-3799. https://doi.org/10.1128/JCM.00549-11
- Bao YP, Li N, Smith JS, Qiao YL. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer. 2008. 18: 71-79.
- Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst. 1995. 87: 796-802. https://doi.org/10.1093/jnci/87.11.796
- Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. A review of human carcinogens-part B: biological agents. Lancet Oncol. 2009.10: 321-322. https://doi.org/10.1016/S1470-2045(09)70096-8
- Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010. 202: 1789-1799. https://doi.org/10.1086/657321
- Cattani P, Siddu A, D'Onghia S, Marchetti S, Santangelo R, Vellone VG, Zannoni GF, Fadda G. RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. J Clin Microbiol. 2009. 47: 2136-2141. https://doi.org/10.1128/JCM.01733-08
- Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005. 366: 991-998. https://doi.org/10.1016/S0140-6736(05)67069-9
- Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989. 243: 934-940. https://doi.org/10.1126/science.2537532
- Ergunay K, Misirlioglu M, Pinar F, Tuncer ZS, Tuncer S, Ustacelebi S. Human papilloma virus DNA in cervical samples with cytological abnormalities and typing of the virus. Mikrobiyol Bul. 2007. 41: 219-226.
- Gaarenstroom KN, Melkert P, Walboomers JM, Van Den Brule AJ, Van Bommel PF, Meyer CJ, Voorhorst FJ, Kenemans P, Helmerhorst TJ. Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynecol Cancer. 1994. 4: 73-78. https://doi.org/10.1046/j.1525-1438.1994.04020073.x
- Hong SR, Kim IS, Kim DW, Kim MJ, Kim AR, Kim YO, Kim HS, Rha SH, Park GS, Park YK, Park YS, Park HS, Suh KS, Sohn JH, Shin MK, Oh HK, Yun KJ, Yoon HK, Lee SN, Lee AW, Lee HJ, Cho HY, Choi C, Jung WW. Prevalence and genotype distribution of cervical human papillomavirus DNA in Korean women: a multicenter study. Korean J Pathol. 2009. 43: 434-342. https://doi.org/10.4132/KoreanJPathol.2009.43.4.342
- Im JE, Shim MJ, Ryang YS, Lee DC. Human papillomavirus testing with hybrid capture II and DNA chip. J Exp Biomed Sci. 2005. 11: 51-56.
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011. 61: 69-90. https://doi.org/10.3322/caac.20107
- Laudadio J. Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screening. Adv Anat Pathol. 2013. 20: 158-167. https://doi.org/10.1097/PAP.0b013e31828d1893
- Levin AJ, Momandd J, Finlay CA. The p53 tumor supressor gene. Nature. 1991. 351: 453-456. https://doi.org/10.1038/351453a0
- Kim YK, Park YP. Analysis of telomerase activity by HPV E6/E7 expression in SW13. J Exp Biomed Sci. 2006. 12: 399-403.
- Kim SH, Lee DS, Kim Y, Kim GH, Park SJ, Choi YI, Kim TU, Park KH, Lee HY. Clinical evaluation of human papillomavirus DNA genotyping assay to diagnose women cervical cancer. J Exp Biomed Sci. 2012. 18: 123-130.
-
Kim SH, Lee DS, Park SJ, Kim TU, Jeon BY, Park KH, Lee HY. REBA
$HPV-ID^{(R)}$ for efficient genotyping of human papillomavirus in clinical samples from Korean patients. J Med Virol. 2012. 84: 1248-1253. https://doi.org/10.1002/jmv.23334 - Lee DS, Kim SH, Park SJ, Jin HW, Kim TU, Park KH, Lee HY. Human papillomavirus prevalence in Gangwon province using reverse blot hybridization assay. Korean J Pathol. 2011. 45: 348-353. https://doi.org/10.4132/KoreanJPathol.2011.45.4.348
- Im JA, Shim MJ, Ryang YS, Lee DC. Human papillomavirus testing with Hybrid Capture II and DNA chip. J Exp Biomed Sci. 2005. 11: 51-56.
- Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and years of publication. Int J Cancer. 2011. 128: 927-935. https://doi.org/10.1002/ijc.25396
- Lee DS, Kim GH, Kim SH, Park SY, Wang HY, Park SJ, Han Lin, Yubo Ren, Li Yingxue, Park KH, Lee HY. Human papillomavirus distribution among women in western Shandong province, East China using reverse blot hybridization assay. Biomed Sci Lett. 2015. 21: 69-76. https://doi.org/10.15616/BSL.2015.21.2.69
- Okadome M, Saito T, Tanaka H, Nogawa T, Furuta R, Watanabe K, Kita T, Yamamoto K, Mikami M, Takizawa K. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2. J Obstet Gynaecol Res. 2014. 40: 561-569. https://doi.org/10.1111/jog.12202
- Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999. 49: 33-64. https://doi.org/10.3322/canjclin.49.1.33
- Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990. 63: 1129-1136. https://doi.org/10.1016/0092-8674(90)90409-8
- Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer. 1998. 75: 536-545. https://doi.org/10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U
- Yugawa T, Kiyono T. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol. 2009. 19: 97-113. https://doi.org/10.1002/rmv.605
- zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009. 384: 260-265. https://doi.org/10.1016/j.virol.2008.11.046